Filing Details
- Accession Number:
- 0001070081-20-000083
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-04-21 16:13:22
- Reporting Period:
- 2020-04-17
- Accepted Time:
- 2020-04-21 16:13:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1070081 | Ptc Therapeutics Inc. | PTCT | Pharmaceutical Preparations (2834) | 043416587 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1579003 | Steven Allan Jacobson | C/O Ptc Therapeutics, Inc. 100 Corporate Court South Plainfield NJ 07080 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-04-17 | 2,100 | $10.85 | 10,598 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-04-17 | 2,100 | $50.16 | 8,498 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-04-20 | 17,900 | $10.85 | 26,398 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-04-20 | 8,147 | $50.58 | 18,251 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-20 | 9,653 | $51.41 | 8,598 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-20 | 100 | $52.16 | 8,498 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right To Buy) | Disposition | 2020-04-17 | 2,100 | $10.85 | 2,100 | $10.85 |
| Common Stock | Stock Option (Right To Buy) | Disposition | 2020-04-20 | 17,900 | $10.85 | 17,900 | $10.85 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 60,900 | 2023-05-15 | No | 4 | M | Direct | |
| 43,000 | 2023-05-15 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right To Buy) | $490.80 | 2021-04-27 | 250 | 250 | Direct | |
| Common Stock | Stock Option (Right To Buy) | $218.40 | 2022-01-10 | 83 | 83 | Direct | |
| Common Stock | Stock Option (Right To Buy) | $27.05 | 2024-01-27 | 10,000 | 10,000 | Direct | |
| Common Stock | Stock Option (Right To Buy) | $51.00 | 2025-01-01 | 12,000 | 12,000 | Direct | |
| Common Stock | Stock Option (Right To Buy) | $30.86 | 2026-01-03 | 12,000 | 12,000 | Direct | |
| Common Stock | Stock Option (Right To Buy) | $11.23 | 2027-01-02 | 12,000 | 12,000 | Direct | |
| Common Stock | Stock Option (Right To Buy) | $18.01 | 2028-01-02 | 14,000 | 14,000 | Direct | |
| Common Stock | Stock Option (Right To Buy) | $33.02 | 2029-01-21 | 14,000 | 14,000 | Direct | |
| Common Stock | Stock Option (Right To Buy) | $51.16 | 2030-01-28 | 10,000 | 10,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2021-04-27 | 250 | 250 | Direct |
| 2022-01-10 | 83 | 83 | Direct |
| 2024-01-27 | 10,000 | 10,000 | Direct |
| 2025-01-01 | 12,000 | 12,000 | Direct |
| 2026-01-03 | 12,000 | 12,000 | Direct |
| 2027-01-02 | 12,000 | 12,000 | Direct |
| 2028-01-02 | 14,000 | 14,000 | Direct |
| 2029-01-21 | 14,000 | 14,000 | Direct |
| 2030-01-28 | 10,000 | 10,000 | Direct |
Footnotes
- This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 4, 2020.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $50.00 to $50.37 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $50.01 to $51.00 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $51.01 to $51.99 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Currently exercisable.
- This option was granted on January 29, 2020 and vests over one year in twelve equal monthly installments, commencing on February 29, 2020.
Billionaire Hedge Funds
